Xuedan Jiao

No ORCID on file · 7 papers in corpus · active 2021-2024

Study types

  • article 4
  • other 2
  • preprint 1

Condition tags

  • mesh:D004715 3
  • infertility 3
  • adenomyosis 3
  • endometrioma 2
  • endometriosis 1
article 2024
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-024-03302-7
article 2023
Free radical biology & medicine ·doi:10.1016/j.freeradbiomed.2022.12.105
article 2022
Frontiers in endocrinology ·doi:10.3389/fendo.2022.902083

Purpose This study aimed to develop a predictive tool for live birth in women with adenomyosis undergoing in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI) treatment. Methods A total of 424 patients with adenomyosis who u…

preprint 2021
·doi:10.21203/rs.3.rs-842214/v1

Abstract Background There is few predictive tools for live birth in women with adenomyosis, which provide further personalized and clinically specific information related to individualized decisions making during IVF/ICSI treatment. Methods…

article 2021
Frontiers in endocrinology ·doi:10.3389/fendo.2021.739228

Purpose To determine the impact of ovarian endometrioma per se on in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) outcomes. Methods This retrospective study was conducted using two groups. The endometrioma group consisted…

other 2021
BMJ open ·doi:10.1136/bmjopen-2020-040563

OBJECTIVE: The objective of this retrospective cohort study was to explore the optimal range of the total progressive motile sperm count (TPMSC) for live birth in couples with varying infertility diagnosis undergoing intrauterine inseminati…

other 2021
Frontiers in endocrinology ·doi:10.3389/fendo.2021.609771

OBJECTIVE: This study aimed to compare the ultra-long gonadotropin-releasing hormone agonist (GnRH-a) protocol and the long GnRH-a protocol during in vitro fertilization (IVF) or intracytoplasmic sperm (ICSI) treatment on fertility outcomes…